Diabetes Update 2017 (Home Study)

Activity Preview

If you provide health care services to patients with diabetes, you need to know all the updates to national guidelines for their care. You should also know where newly approved antidiabetic agents fit into current treatment approaches, the latest data regarding safe use of antidiabetic agents, and the treatment strategies that are likely to yield the best outcomes. Learn about these updates and more at this expert-led session.

This home study is an archived webinar from the APhA2017 Annual Meeting held in San Francisco, CA.

Learning Objectives

After participating in "Diabetes Updates 2017 (Home Study)", the pharmacist will be able to:

  1. Summarize important recent changes to the American Diabetes Association Standards of Medical Care in Diabetes and other authoritative guidelines.
  2. Describe evidence regarding the risks and benefits of new and emerging medications and products for the management of patients with diabetes.
  3. Identify noteworthy findings from recent large clinical trials that have the potential to influence diabetes care.
  4. Explain how to apply emerging information to the care of patients with diabetes.

Activity Type: Knowledge-based

Target Audience: Pharmacists 

Learning Level: Level 2

Accreditation Information 

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). This home study CPE activity is approved for 1.5 contact hours of CPE credit (0.15 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-17-065-H04-P.

To obtain credit for "Diabetes Updates 2017 (Home Study)" complete the assessment with a grade of 70% or better, complete the evaluation and CLAIM credit. Participants will need to have a valid pharmacist.com username and password to claim credit. After your credit has been claimed, please visit CPE monitor for your transcript.  

APhA continuing pharmacy education policy provides you with two opportunities to successfully complete this continuing pharmacy education examination. Please note that you will not be permitted to submit the examination a third time. All exam questions are randomized and may not appear in the same order as printed. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.

Initial Release Date: March 26, 2017

Expiration date: March 26, 2020 - NO CREDIT GRANTED AFTER THIS DATE


"Diabetes Updates 2017 (Home Study)" is an archived webinar education activity for pharmacists developed by the American Pharmacists Association.                                                                                   


Staci-Marie Norman, PharmD declares that she is a speaker for Eli Lilly and Company and that her spouse is employed by Takeda Pharmaceutical Company.

Jennifer Smith declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria.

APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, please visit the APhA website at www.pharmacist.com/apha-disclosures.  Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, Associate Director of Content Development at the American Pharmacists Association. 


The fee for this activity is $29 for APhA members and $49 for non-members.

System Requirements

Computer and Internet access is required to complete this activity.  Please visit our website to view the Technology System Requirements to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-17-065-H04-P 0.15 CEUs March 26, 2017 - March 26, 2020